PMC:6562565 / 40962-41391 JSONTXT

{"project":"MyTest","denotations":[{"id":"31244820-24660106-35366078","span":{"begin":55,"end":58},"obj":"24660106"},{"id":"31244820-23983257-35366079","span":{"begin":71,"end":74},"obj":"23983257"},{"id":"31244820-24660106-35366080","span":{"begin":114,"end":117},"obj":"24660106"},{"id":"31244820-24660106-35366081","span":{"begin":190,"end":193},"obj":"24660106"},{"id":"31244820-23983257-35366082","span":{"begin":210,"end":213},"obj":"23983257"},{"id":"31244820-24660106-35366083","span":{"begin":278,"end":281},"obj":"24660106"},{"id":"31244820-24660106-35366086","span":{"begin":352,"end":355},"obj":"24660106"},{"id":"31244820-23983257-35366087","span":{"begin":387,"end":390},"obj":"23983257"},{"id":"31244820-23983257-35366088","span":{"begin":412,"end":415},"obj":"23983257"},{"id":"31244820-24660106-35366089","span":{"begin":425,"end":428},"obj":"24660106"},{"id":"31244820-24660106-35366078","span":{"begin":55,"end":58},"obj":"24660106"},{"id":"31244820-24660106-35366081","span":{"begin":190,"end":193},"obj":"24660106"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"CTLA-4 ICB \u0026 CD73 inhibition ➣ anti-CTLA-4mAbs:\n9H10 (389)\nUC10-4F10 (382)\n➣ CD73 pharmacologic inhibitor:\nAPCP (389)\n➣ anti-CD73mAb:\nTY/23 (382) ➣ Breast: 4T1.2 (382)\n➣ Melanoma: B16F10 (389)\n➣ Colon: MC38 (382)\n➣ Prostate: RM-1 (382) ➣ Primary tumor expansion rate ↓ (382, 389)\nCD8+ \u003e\u003e CD4+ T cells (382)\n➣ Survival ↑ (382) ↑ CD8+, CD4+ T cells (389)↑ Tumor-specific CD8+ T cells (382)↑ IFN-γ, T-bet mRNA (382)↑ IFN-γ (389)"}

{"project":"TEST0","denotations":[{"id":"31244820-6-13-3850226","span":{"begin":55,"end":58},"obj":"[\"24660106\", \"24660106\"]"},{"id":"31244820-11-18-3850227","span":{"begin":71,"end":74},"obj":"[\"23983257\"]"},{"id":"31244820-6-13-3850228","span":{"begin":114,"end":117},"obj":"[\"24660106\"]"},{"id":"31244820-20-27-3850229","span":{"begin":190,"end":193},"obj":"[\"24660106\", \"24660106\"]"},{"id":"31244820-15-22-3850230","span":{"begin":210,"end":213},"obj":"[\"23983257\"]"},{"id":"31244820-39-46-3850231","span":{"begin":278,"end":281},"obj":"[\"24660106\"]"},{"id":"31244820-22-29-3850234","span":{"begin":352,"end":355},"obj":"[\"24660106\"]"},{"id":"31244820-57-64-3850235","span":{"begin":387,"end":390},"obj":"[\"23983257\"]"},{"id":"31244820-82-89-3850236","span":{"begin":412,"end":415},"obj":"[\"23983257\"]"},{"id":"31244820-95-102-3850237","span":{"begin":425,"end":428},"obj":"[\"24660106\"]"},{"id":"31244820-6-13-3850226","span":{"begin":55,"end":58},"obj":"[\"24660106\", \"24660106\"]"},{"id":"31244820-20-27-3850229","span":{"begin":190,"end":193},"obj":"[\"24660106\", \"24660106\"]"}],"text":"CTLA-4 ICB \u0026 CD73 inhibition ➣ anti-CTLA-4mAbs:\n9H10 (389)\nUC10-4F10 (382)\n➣ CD73 pharmacologic inhibitor:\nAPCP (389)\n➣ anti-CD73mAb:\nTY/23 (382) ➣ Breast: 4T1.2 (382)\n➣ Melanoma: B16F10 (389)\n➣ Colon: MC38 (382)\n➣ Prostate: RM-1 (382) ➣ Primary tumor expansion rate ↓ (382, 389)\nCD8+ \u003e\u003e CD4+ T cells (382)\n➣ Survival ↑ (382) ↑ CD8+, CD4+ T cells (389)↑ Tumor-specific CD8+ T cells (382)↑ IFN-γ, T-bet mRNA (382)↑ IFN-γ (389)"}

{"project":"2_test","denotations":[{"id":"31244820-24660106-35366078","span":{"begin":55,"end":58},"obj":"24660106"},{"id":"31244820-23983257-35366079","span":{"begin":71,"end":74},"obj":"23983257"},{"id":"31244820-24660106-35366080","span":{"begin":114,"end":117},"obj":"24660106"},{"id":"31244820-24660106-35366081","span":{"begin":190,"end":193},"obj":"24660106"},{"id":"31244820-23983257-35366082","span":{"begin":210,"end":213},"obj":"23983257"},{"id":"31244820-24660106-35366083","span":{"begin":278,"end":281},"obj":"24660106"},{"id":"31244820-24660106-35366086","span":{"begin":352,"end":355},"obj":"24660106"},{"id":"31244820-23983257-35366087","span":{"begin":387,"end":390},"obj":"23983257"},{"id":"31244820-23983257-35366088","span":{"begin":412,"end":415},"obj":"23983257"},{"id":"31244820-24660106-35366089","span":{"begin":425,"end":428},"obj":"24660106"},{"id":"31244820-24660106-35366078","span":{"begin":55,"end":58},"obj":"24660106"},{"id":"31244820-24660106-35366081","span":{"begin":190,"end":193},"obj":"24660106"}],"text":"CTLA-4 ICB \u0026 CD73 inhibition ➣ anti-CTLA-4mAbs:\n9H10 (389)\nUC10-4F10 (382)\n➣ CD73 pharmacologic inhibitor:\nAPCP (389)\n➣ anti-CD73mAb:\nTY/23 (382) ➣ Breast: 4T1.2 (382)\n➣ Melanoma: B16F10 (389)\n➣ Colon: MC38 (382)\n➣ Prostate: RM-1 (382) ➣ Primary tumor expansion rate ↓ (382, 389)\nCD8+ \u003e\u003e CD4+ T cells (382)\n➣ Survival ↑ (382) ↑ CD8+, CD4+ T cells (389)↑ Tumor-specific CD8+ T cells (382)↑ IFN-γ, T-bet mRNA (382)↑ IFN-γ (389)"}